Возраст домена | 21 год |
Дата окончания | Истек срок регистрации |
PR | 5 |
ИКС | 0 |
Страниц в Google | 348 |
Страниц в Яндексе | 266 |
Dmoz | Да |
Яндекс Каталог | Нет |
Alexa Traffic Rank | 6144644 |
Alexa Country | Нет данных |
История изменения показателей | Авторизация |
Идет сбор информации... Обновить
CLL Topics: Therapies, Research and Patient Education for Chronic Lymphocytic Leukemia
patient education, CLL, chronic lymphocytic leukemia, volunteer, therapy choices, chemotherapy, immunotherapy, clinical trial, chemoimmunotherapy, stem cell transplant, bone marrow, blood cancer, leukaemia, vaccine, CLLTopics.org
CLL Topics dedicated to the fight against chronic lymphocytic leukemia - patient education and support, clinical research and new therapies
UTF-8
167.11 КБ
2 500
83 331 симв.
69 592 симв.
Данные предоставлены сервисом semrush
Сайт | Общие фразы | PR | тИЦ | Alexa Rank | Alexa Country | |
---|---|---|---|---|---|---|
cllsupport.org.uk | 60 | 3 |
0 | 1909729 | Нет данных | |
clldiary.blogspot.com | 37 | 2 |
0 | Нет данных | Нет данных | |
cancerinformation.com | 27 | 4 |
20 | Нет данных | Нет данных | |
rituxan.com | 23 | 5 |
0 | 1434575 | 312612 | |
ascopost.com | 22 | 4 |
10 | 154433 | 58825 | |
fightcll.org | 19 | 1 |
0 | Нет данных | Нет данных | |
campath.com | 18 | 4 |
0 | 7317112 | Нет данных | |
cllglobal.org | 15 | 4 |
0 | 11995997 | Нет данных | |
livingwithcll.info | 14 | 2 |
0 | 8519607 | Нет данных | |
cll-nhl.com | 13 | 3 |
0 | 4082292 | Нет данных | |
Еще 40 сайтов после авторизации |
Данные предоставлены сервисом semrush
Счетчик | Посетители за 24 часа | Просмотры | Просмотров на посетителя |
---|---|---|---|
Google Analytics | Нет доступа | Нет доступа | n/a |
Данные linkpad ( 30 Августа 2012 ) | |
Количество ссылок на сайт | 27 |
Количество доменов, которые ссылаются на сайт | 25 |
Количество найденных анкоров | 14 |
Исходящие (внешние) ссылки домена | 570 |
Количество доменов, на которые ссылается сайт | 279 |
Количество исходящих анкоров | 487 |
Внешние ссылки главной страницы ( 11 ) | |
csgoskinsites.com/csgo-betting/ | csgo betting |
twin.com/nz | online casino nz |
fi.twin.com | netticasino |
de.twin.com/slots | Slot Spiele |
ezy.com | csgo case |
twin.com/slots | free slots |
onlinecasinolovers.com | best online casino uk |
leon.ru/mobile | букмекерская контора |
br.twin.com | cassino online |
content.nejm.org/cgi/reprint/NEJMe0706501v2.pdf | full editorial |
xn--bstacasinoonline-vnb.site/ | bästa casino online |
Внутренние ссылки главной страницы ( 173 ) | |
#top | <img> |
Contents.html | Site Map |
Alert/index.html | Topics Alert |
Primer.html | A CLL Primer |
AboutUs.html | About Us |
Feedback.html | Feedback |
updates_subdomain/index.html | CLL Topics Updates |
updates_subdomain/4699-news-you-can-use.html | News you can use |
Obituary.html | <img> |
MOABs/Veltuzumab.html | Veltuzumab: Another Anti-CD20 Monoclonal in Clinical Trials |
SponsoredProjects/NKCellTherapy.html | NK-cell Therapy: Better than a transplant? |
DC/LivingLonger.html | Are CLL Patients Living Longer? |
Chemo/SingleAgentFludarabine.html | Single Agent Fludarabine: Definitely Not the Gold Standard |
BMT/NCIMUD.html | MUD Transplants at the NCI |
Chemo/Treanda.html | Treanda: A Facelift for Bendamustine |
Complications/ITP.html | ITP: Immune Thrombocytopenia |
DC/Refractory.html | Refractory CLL |
SponsoredProjects/JabNDab.html | Jab & Dab: We Have Liftoff! |
Alert/direct_display_alert_reqnum_253.html | Topics Alert #253: Quality of Life with CLL |
Campath/JumpingtheGun.html | Jumping the Gun |
PhysCor/DrExpert.html | What Say You, Dr. Expert? |
tchoices/RIUnderappreciated.html | Radioimmunotherapy: Underappreciated Option? |
Announcements/RICuts.html | Radioimmunotherapy Reimbursement Cuts |
PI/Murky.html | FISHing in Murky Waters |
BMT/CBTStateoftheArt.html | Cord Blood Transplants: State of the Art |
BMT/Catch22.html | Catch 22 – The Transplant Minefield |
CI/StrategyTactics.html | Strategy and Tactics |
MOABs/Bexxar.html | Bexxar: An Introduction to Radioimmunotherapy |
BMT/GVHDDevelopments.html | GVHD: A Pebble in the Transplant Shoe |
Case_Studies/JennysStory.html | Jenny Tells the Forest Story |
ClinTrials/CAT8015.html | CAT8015 – A Trojan Horse |
MOABs/Lumi.html | Lumiliximab: The Next Drug in CLL? |
Chemo/Revlimid.html | Revlimid to the Rescue? |
ClinTrials/HuFLAnnouncement.html | HuMax-CD20 Monotherapy in Refractory Follicular Lymphoma |
ClinTrials/HuFCAnnouncement.html | HuMax+FC Announcement |
SponsoredProjects/RplusFenretinide.html | Rituxan plus Fenretinide: a Match Made in Heaven? |
BMT/TransplantsAlmostFree.html | Stem Cell Transplants - Free of Charge (Almost!) |
MeetingsConferences/ASH2006Highlights.html | ASH 2006 Highlights |
Case_Studies/GregsStory.html | Greg's Story |
Announcements/AgentOrange.html | <img> |
TIS/Tregs.html | Tregs Revealed. |
SponsoredProjects/SponsorshipPhilosophy.html | Our Sponsorship Philosophy |
Complications/MostatRisk.html | Who Is Most at Risk? |
PhysCor/SteroidCampath.html | steroid-Campath combinations |
SponsoredProjects/RituxanShaving.html | CD20 Shaving with Rituxan |
Complications/mrsa.html | The Dangers of Drug Resistant Bacterial Infections |
ClinTrials/HuMaxRisksRewards.html | HuMax-CD20 Risks and Rewards |
ClinTrials/SmarterMonoclonal.html | A Smarter Monoclonal on Trial |
Complications/EnemyWithin.html | The Enemy Within |
Complications/InfectiousComplications.html | Infectious Complications of CLL |
Complications/EpoGettingDarker.html | The Dark Side of EPO - Getting Darker |
tchoices/BestPractices.html | Standards for Best Practices |
ClinTrials/HarveyIsBack.html | Genmab in the News |
SponsoredProjects/LHF.html | Improving Immunizations |
datafiles/TestingthePowerofGreenTea.pdf | Testing the Power of Green Tea |
Chemo/FCvsF.html | F+C vs F |
Vaccines/VaccineTrials.html | A Vaccine Trial for CLL Patients |
Case_Studies/ForestBump.html | Forest Bump |
Rituxan/RituxanRoadBlock.html | Harvey Runs into a Road-block |
tchoices/BattleWar.html | Winning the Battle but Losing the War? |
Phyto/LatestonGreenTea.html | Latest on Green Tea |
ClinTrials/CTUPCRvsFCR.html | Clinical Trial Updates |
ClinTrials/FCRLite.html | FCR Lite |
tchoices/RFRisks.html | new article on RF Therapy |
ClinTrials/HuMax.html | Results from GenMab's HuMax Clinical Trial |
ChronInflam/AvianFlu.html | Avian Flu and CLL |
PI/MCLWolf.html | MCL - a Wolf in CLL Clothing |
ClinTrials/Bcl2Target.html | Targeting Bcl-2 |
ChronInflam/FluPrep.html | Flu Preparedness |
CTLTherapy/CD20Target.html | Autologous CD-20 Targeted T-Cell Therapy |
SponsoredProjects/PAlphaKickoff.html | Project Alpha Kickoff |
ClinTrials/MplusFCRBrit.html | FMC + R Brit. Version |
CaseStudies/ConventionalWisdom.html | Death by Conventional Wisdom |
ClinTrials/MitoxantroneplusFCRpartB.html | More on Mitoxantrone + FCR |
ClinTrials/MitoxantroneplusFCR.html | Mitoxantrone + FRC |
tchoices/RiskAdaptedStrategies.html | Risk-adapted Strategies |
BMT/GVHD.html | This article |
BMT/OnlyRealCure.html | The Only Real Cure Out There, for Now |
ClinTrials/17AAGClinTrial.html | 17-AAG - An Important New Trial Has Been Announced |
Chemo/17AAG.html | 17-AAG |
Campath/CampathplusGCSF.html | Campath plus G-CSF |
PhysCor/FrankArbiserInterview.html | Honokiol: Expert Interview |
Phyto/honokiol.html | Honokiol |
tchoices/IVIgBenefits.html | Possible Benefits of IVIg |
PI/PrognosticandMonitoringTestPackages.html | Prognostic and Monitoring Tests |
Announcements/CLLGlobalResearchFoundation.html | CLL Global |
ClinTrials/RituxanplusCampathMayo.html | Clinical Trial to Test Rituxan plus Short Duration Campath |
Campath/ProlongedSurvival.html | Good News for the Tough Cases |
DC/DawnofaNewEra.html | The Dawn of a New Era |
PI/ProgressonPrognostics.html | Progress on Prognostics |
PatCor/gettingagrip.html | Getting a Grip |
PhysCor/AWTY.html | Are We There Yet? |
Phyto/Omega3.html | Omega-3 Fatty Acids |
Complications/RealPain.html | A Real Pain in the Mouth |
BMT/MatchingMadeSimple.html | Matching Made Simple |
MOABs/SonsofRituxanandCampath.html | Sons of Rituxan and Campath |
MeetingsConferences/ASH2004Highlights.html | ASH 2004 Highlights |
CellBio/Epigenetics.html | Epigenetics |
tchoices/ShoppingForTherapies.html | Shopping for Therapies |
Alert/direct_display_alert_reqnum_47.html | Those Aches and Pains |
Chemo/TargetMitochondrion.html | Exciting New Drugs on the Horizon |
PI/ZAP-70_IgVH.html | ZAP-70 & IgVH Gene Mutation |
Complications/AIHA.html | AIHA: Auto-Immune Hemolytic Anemia |
PatCor/diagnosingyourdoctor.html | Diagnosing Your Doctor |
DC/WorstDay.html | Not the Worst Day of Your Life |
PhysCor/FamilialCLL.html | Familial CLL |
Rituxan/NeupogenBoosterR.html | Neupogen Boosts Rituxan |
VitaminD3/EssentialforHealth.html | : Essential for Health |
tchoices/NotGoldStandard.html | F Monotherapy: Not Gold Standard |
Campath/campath_consolidation.html | Campath Consolidation |
Complications/Dying.html | Dying to Get a Tan? |
tchoices/NeedtoKnow.html | "Need to Know" |
PI/FISHingforAnswers.html | FISH-ing for Answers |
DC/ClonalEvolution.html | Clonal Evolution |
CellBio/AdhesionHomingResistance.html | Adhesion, Homing and Resistance to Therapy |
PI/Type.html | What Type of CLL Do You Have? |
BMT/PrimeronSCTs.html | Primer on Stem Cell Transplants |
Alert/alert_archive.html | Topics Alerts Archive |
datafiles/SpringMayoMag05_CLL.pdf | Information Empowers Leukemia Patients |
patients_corner.html | Patients' Corner |
SupportGroups.html | Support Groups |
TechnicalNotes.html | Navigation Notes |
YourCharts.html | Your Charts |
Reference.html#MSKCC | Memorial Sloan-Kettering |
Textbooks.html | Textbooks |
search_tools.html#Advanced | advanced search form |
Donations.html | Donations |
CurrentArticles.html | Current Articles |
Acknowledgements.html | Acknowledgements |
SponsoredProjects.html | CLL Topics Sponsored Clinical Trials |
datafiles/F2007.pdf | Fiscal 2007 Statement |
datafiles/F2006.pdf | Fiscal 2006 Statement |
datafiles/F2005.pdf | Fiscal 2005 Statement |
datafiles/F2004.pdf | Fiscal 2004 Statement |
datafiles/F2003.pdf | Fiscal 2003 Statement |
datafiles/AR2007.pdf | Annual Report to the Board for 2007 |
datafiles/AR2006.pdf | Annual Report to the Board for 2006 |
datafiles/AR2005.pdf | Annual Report to the Board for 2005 |
datafiles/AR2004.pdf | Annual Report to the Board for 2004 |
datafiles/ArticlesofIncorporationAsAmended.pdf | Articles of Incorporation |
datafiles/BylawsAsAmended.pdf | Bylaws |
datafiles/PublicCharityStatus02252008.pdf | Ruling Confirming Status as Public Charity |
clltopics.org/datafiles/AdvRulingLetter.pdf | IRS Tax Exemption Letter |
clltopics.org/datafiles/ApplicationAdvRuling.pdf | Application for Tax Exemption |
journal_subdomain/index.html | online journal |
don/NotesonFundraising.html | fundraising efforts |
CaseStudies/ForestBump.html | Forest Bump |
Case_Studies/ConventionalWisdom.html | Death by Conventional Wisdom |
BestPractices.html | Best Practices in CLL |
RituxanTherapy.html | Rituxan |
Fludarabine.html | Fludarabine |
CampathTherapy.html | Campath |
HuMaxCD20.html | HuMax-CD20 |
Chemotherapy.html | Traditional Chemotherapy |
Transplants.html | Stem Cell Transplants |
Vaccines.html | Vaccines |
tchoices/GeneTherapy.html | Gene Therapy |
CTLTherapy.html | CTL Therapy |
Angiogenesis.html | Angiogenesis |
Chemoprevention.html | Phytochemicals, Nutrition and Chemoprevention |
Vitamin_d3.html | Vitamin D 3 |
don/Update.html | Donation Status |
PhysiciansCorner.html | Physicians' Corner |
Phyto/DrinkingGreenTea.html | Do You Like Drinking Green Tea? |
Campath/CampathLookingBetter.html | Campath Looking Better and Better |
PI/PrognosisatDiagnosis.html | Prognosis at Diagnosis |
Chemo/DeliveryMethods.html | The "How" Is Often as Important as the "What" |
CellBio/CytogeneticsATMP53.html | Cytogenetics of ATM and TP53 |
ChronInflam/Pulmonary.html | Role of Pulmonary Inflammation in CLL |
Complications/EpoDarkSide.html | The Dark Side of Epoetin |
ChronInflam/WhatUCanDo.html | CLL, Chronic Inflammation and What You Can Do About It |
RHK.html | RHK Saga |
CI/DifficultCaseRHK.html | The Difficult Case of the Round-headed Kid |
Domain Name: CLLTOPICS.ORG
Registry Domain ID: D92285505-LROR
Registrar WHOIS Server: whois.godaddy.com
Registrar URL: http://www.whois.godaddy.com
Updated Date: 2018-12-29T05:58:41Z
Creation Date: 2002-11-16T22:42:17Z
Registry Expiry Date: 2019-11-16T22:42:17Z
Registrar Registration Expiration Date:
Registrar: GoDaddy.com, LLC
Registrar IANA ID: 146
Registrar Abuse Contact Email: abuse@godaddy.com
Registrar Abuse Contact Phone: +1.4806242505
Reseller:
Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited
Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited
Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited
Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited
Registrant Organization: Oring LTD
Registrant State/Province: Malta
Registrant Country: MT
Name Server: NS73.DOMAINCONTROL.COM
Name Server: NS74.DOMAINCONTROL.COM
URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/)
>>> Last update of WHOIS database: 2019-01-29T19:45:05Z <<<
For more information on Whois status codes, please visit https://icann.org/epp
Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.
The Registrar of Record identified in this output may have an RDDS service that can be queried for additional information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.
Sitemap: http://clltopics.org/sitemap.xml
США - 216.239.32.21
США - 216.239.34.21
США - Маунтин-Вью - 216.239.36.21
США - 216.239.38.21
HTTP/1.1 200 OK
Date: Wed, 18 Dec 2019 16:02:15 GMT
Server: Apache
Last-Modified: Tue, 12 Nov 2019 14:48:49 GMT
Accept-Ranges: bytes
Content-Length: 171123
Content-Type: text/html
Кнопка для анализа сайта в один клик, для установки перетащите ссылку на "Панель закладок"